№ lp_1_23671
File format: docx
Character count: 81561
File size: 142 KB
The document outlines specific quality requirements for suppliers, including guidelines for the procurement process, inspections, and material management.
Note:
Year
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2023
Region / City:
Not specified
Topic:
Supplier Quality Requirements
Document Type:
Standards / Quality Assurance Guidelines
Agency / Organization:
Northrop Grumman Mission Systems
Author:
Not specified
Target Audience:
Suppliers, Subcontractors
Period of Validity:
As of May 2023
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2023
Region / City:
Global
Subject:
Supplier Quality Requirements
Document Type:
Standard
Organization:
Northrop Grumman
Author:
Northrop Grumman
Target Audience:
Suppliers, Contractors, Subcontractors
Period of validity:
As specified in procurement documents
Approval Date:
May 2023
Date of Amendments:
As of May 2023, October 2023, February 2024, June 2024, October 2024
Year:
2023
Note:
Region / City
Theme:
Quality Assurance, Supplier Requirements, Procurement
Document Type:
Standard Operating Procedure
Organization / Institution:
Northrop Grumman
Target Audience:
Suppliers, Subcontractors, Quality Assurance Teams
Year:
2026
Region / City:
Not specified
Theme:
Quality assurance, procurement
Document Type:
Technical specifications, quality requirements
Organization / Institution:
Northrop Grumman
Author:
Not specified
Target Audience:
Suppliers, subcontractors
Effective Period:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Agency:
United States Securities and Exchange Commission
Form number:
Form 25
Document type:
Regulatory filing form
Jurisdiction:
United States
Legal basis:
Securities Exchange Act of 1934
Applicable rules:
Rule 12d2-2 (17 CFR 240.12d2-2); Rule 19d-1 (17 CFR 240.19d-1)
OMB control number:
3235-0080
OMB expiration date:
March 31, 2021
Filing system:
EDGAR
Effective delisting period:
10 days after filing
Effective withdrawal of registration period:
90 days after filing
Revision identifier:
SEC 1654 (03-06)
Year:
2025
Region / city:
Australia
Subject:
Oncology, Pharmaceutical Submission
Document Type:
Pharmaceutical Benefits Scheme (PBS) Submission
Organ / Institution:
PBAC (Pharmaceutical Benefits Advisory Committee)
Author:
JANSSEN-CILAG PTY LTD
Target Audience:
Medical practitioners, healthcare professionals
Period of validity:
Ongoing
Approval Date:
Pending
Date of modifications:
N/A
Year:
2025
Region / City:
Uganda
Theme:
Procurement, Health Services, Public Contracts
Document Type:
Pre-Qualification Notice
Authority:
Mulago Specialised Women and Neonatal Hospital
Author:
Not specified
Target Audience:
Providers, Contractors, Suppliers
Period of Validity:
2025-2028
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2024
Region / Country:
Australia
Therapeutic Area:
Gastroenterology
Type of Document:
Regulatory submission / PBAC evaluation
Product:
Budesonide 4 mg suppository (Budenofalk®)
Comparator:
Budesonide 2 mg foam (Budenofalk®), prednisolone suppositories and enemas, hydrocortisone acetate enemas
Regulatory Authority:
TGA (Therapeutic Goods Administration)
Intended Use:
Short-term treatment of mild to moderate ulcerative colitis limited to the rectum
Prescriber Type:
Medical practitioners, Nurse practitioners
PBS Benefit Type:
Unrestricted
Maximum Quantity:
1 pack, 30 units
Treatment Duration:
up to 8 weeks per script
Clinical Evidence:
Phase 3, randomized, double-blind, double-dummy, non-inferiority trial (BUS-4/UCA)
Year:
2025
Region / City:
Windhoek
Subject:
Public Administration, Consultancy, Research
Document Type:
Official Announcement
Institution:
Namibia Institute of Public Administration and Management (NIPAM)
Author:
NIPAM
Target Audience:
Facilitators, Researchers, Consultants, Public Sector Experts
Period of Validity:
Until 10 February 2025
Approval Date:
Not specified
Date of Last Modification:
Not specified
Year:
2011
Regulation:
The Companies Regulations 2011, as amended
Region / Market:
Johannesburg Stock Exchange (JSE)
Document Type:
Regulatory guidance / compliance document
Scope:
Pre-Listing Statements (PLS), Revised Listing Particulars (RLP), Circulars
Language:
English
Applicable Parties:
Issuers and applicants seeking listing on JSE
Requirements:
Disclosure obligations, material contracts, corporate actions
Website Obligation:
Operational website for disclosure compliance
Audience:
Investors, shareholders
Year:
[Year]
Region / City:
Wellington
Topic:
Securities listing and quotation
Document Type:
Application
Organization:
NZ RegCo
Author:
[Issuer Name]
Target Audience:
NZX, securities issuers
Effective Period:
[Date]
Approval Date:
[Date]
Amendment Date:
[Date]
Year:
2023
Region / city:
Australia
Topic:
Oncology, Pharmaceuticals
Document Type:
Resubmission
Institution:
Australian Government, Pharmaceutical Benefits Advisory Committee
Author:
AstraZeneca Pty Ltd.
Target Audience:
Healthcare professionals, regulatory bodies
Effective Period:
Ongoing
Approval Date:
November 2021
Date of Changes:
November 2021
Note:
Year
Year:
2021
Region / city:
United States
Subject:
COVID-19, Federal Audit Clearinghouse
Document Type:
Memo
Institution:
Department of Education
Author:
Phillip Juengst, Deputy Assistant Secretary
Target Audience:
Grant recipients of the Department of Education
Effective Date:
August 9, 2021
Date of Approval:
August 4, 2021
Questions:
[email protected]
Period of Applicability:
For single audit submissions on or after August 9, 2021
Document Description:
Guidance on how to report subprogram Assistance Listing Numbers (ALNs) with their alphas in the Federal Audit Clearinghouse single audit submission form for Department of Education programs.
Year:
2021
Region / city:
South Africa
Topic:
Financial Instruments, Exchange-Traded Notes
Document Type:
Listing Announcement
Organ / Institution:
FirstRand Bank Limited
Author:
FirstRand Bank Limited
Target Audience:
Investors, Financial Institutions
Period of Validity:
17 August 2021 – 17 August 2026
Approval Date:
17 August 2021
Amendment Date:
None
Year:
2018
Region / city:
Australia
Topic:
Immunisation, Hepatitis B
Document type:
Report
Agency / institution:
PBAC (Pharmaceutical Benefits Advisory Committee)
Author:
Chief Medical Officer
Target audience:
Healthcare professionals, policymakers
Period of validity:
Until 31 December 2019
Date of approval:
June 2018
Date of amendments:
None
Year:
2021
Event:
Expert meeting
Location:
Online
Organization:
UNESCO
Topic:
Intangible cultural heritage, listing mechanisms
Type of document:
Report / Meeting overview
Author:
Rieks Smeets
Target audience:
UNESCO member states, cultural heritage experts
Dates of event:
26–27 May 2021
Time:
13:00–16:00 (Paris time / UTC+2)
Historical period covered:
1960s–2008
Year:
2021
Region / city:
Online
Subject:
Intangible Cultural Heritage
Document type:
Background Paper
Organization:
UNESCO
Author:
UNESCO Secretariat
Target audience:
Experts, States Parties, practitioners in the field of intangible cultural heritage
Duration:
May 2021 – ongoing
Approval date:
Not provided
Amendment date:
Not provided
Year:
2020
Organization:
UNESCO
Session:
Eighth session of the General Assembly of the States Parties
Document type:
Report / Summary
Agenda item:
11 – Update on the reflection on the listing mechanisms of the Convention
Related decisions:
13.COM 6, 13.COM 10, 14.COM 14
Meeting location:
UNESCO Headquarters, Room I
Context:
Summary of progress and reflections on the implementation and evaluation of the listing mechanisms of the 2003 Convention, including impacts of COVID-19 and planned procedural revisions.
Year:
2023
Region / City:
Australian Capital Territory
Topic:
Death investigations, mental health, public safety
Author:
Coroner Archer
Target Audience:
Legal professionals, public safety authorities
Period of Validity:
N/A
Approval Date:
4 October 2023
Date of Changes:
N/A